Xeris Biopharma Holdings, Inc.
XERS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001867096
In the last 90 days, Xeris Biopharma Holdings, Inc. insiders filed 0 open-market purchases and 10 sales; 242 institutions reported holding it in 13F filings for Q2 2026, worth $857.1M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Xeris Biopharma Holdings, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 120
- +9 vs. Q3 2023
- Shares held
- 59.9M
- +4.89M (+8.9%) vs. Q3 2023
- Total value
- $140.8M
- +$38.5M (+37.6%) vs. Q3 2023
- New holders
- 21
- 37 more added
- Sold out
- 12
- 32 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting XERS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 242 | $857.1M |
| Q1 2026 | 239 | $610.3M |
| Q4 2025 | 227 | $792.0M |
| Q3 2025 | 231 | $789.3M |
| Q2 2025 | 201 | $422.9M |
| Q1 2025 | 199 | $480.9M |
| Q4 2024 | 162 | $222.2M |
| Q3 2024 | 144 | $182.2M |
| Q2 2024 | 135 | $136.6M |
| Q1 2024 | 142 | $133.7M |
| Q4 2023 | 120 | $140.8M |
| Q3 2023 | 111 | $102.3M |
| Q2 2023 | 105 | $146.7M |
| Q1 2023 | 92 | $80.6M |
| Q4 2022 | 97 | $71.6M |
| Q3 2022 | 101 | $89.3M |
| Q2 2022 | 103 | $91.3M |
| Q1 2022 | 103 | $129.2M |
| Q4 2021 | 92 | $120.2M |
| Q3 2021 | 71 | $42.9M |
| Q2 2021 | 94 | $114.9M |
| Q1 2021 | 103 | $149.7M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Xeris Biopharma Holdings, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lazard Asset Management LLC | 403,813 | $948.0K | 0.00% | +88,326+28.0% | Added |
| Gsa Capital Partners LLP | 416,267 | $978.0K | 0.08% | +35,036+9.2% | Added |
| Nuveen Asset Management, LLC | 424,972 | $998.7K | 0.00% | −287,725−40.4% | Reduced |
| Ameriprise Financial Inc | 520,121 | $1.22M | 0.00% | −67,817−11.5% | Reduced |
| Tudor Investment Corp Et Al | 553,411 | $1.30M | 0.02% | −88,087−13.7% | Reduced |
| Invenomic Capital Management LP | 568,619 | $1.34M | 0.07% | +568,619 | New |
| Redmile Group, LLC | 1,046,587 | $2.46M | 0.09% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 1,054,610 | $2.48M | 0.00% | +179,200+20.5% | Added |
| Northern Trust Corp | 1,165,363 | $2.74M | 0.00% | +20,146+1.8% | Added |
| Morgan Stanley | 1,221,358 | $2.87M | 0.00% | +583,126+91.4% | Added |
| Renaissance Technologies LLC | 1,381,640 | $3.25M | 0.01% | +359,600+35.2% | Added |
| Millennium Management LLC | 1,547,955 | $3.64M | 0.00% | −726,189−31.9% | Reduced |
| State Street Corp | 2,724,126 | $6.40M | 0.00% | +154,004+6.0% | Added |
| Geode Capital Management, LLC | 2,892,077 | $6.80M | 0.00% | +118,784+4.3% | Added |
| Rosalind Advisors, Inc. | 3,543,685 | $8.33M | 6.97% | +3,543,685 | New |
| MPM Oncology Impact Management LP | 3,847,232 | $9.04M | 2.12% | −140,735−3.5% | Reduced |
| Caxton Corp | 5,641,920 | $13.3M | 71.57% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 5,937,000 | $14.0M | 6.03% | +21,628+0.4% | Added |
| Vanguard Group Inc | 7,086,345 | $16.7M | 0.00% | +60,181+0.9% | Added |
| BlackRock Inc. | 10,011,391 | $23.5M | 0.00% | +637,149+6.8% | Added |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −655,000−100.0% | Sold out |
| Opaleye Management Inc. | 0 | $0 | 0.00% | −390,000−100.0% | Sold out |
| Sinecera Capital, LLC | 0 | $0 | 0.00% | −253,101−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −185,221−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −53,883−100.0% | Sold out |
| CSS LLC | 0 | $0 | 0.00% | −24,991−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −24,700−100.0% | Sold out |
| Sawtooth Solutions, LLC | 0 | $0 | 0.00% | −11,048−100.0% | Sold out |
| Bleakley Financial Group, LLC | 0 | $0 | 0.00% | −11,048−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −10,384−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −119−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −95−100.0% | Sold out |